Explore our materials

Filters

Results (14767)

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Efficacy of Two-Drug Regimen of Dolutegravir Plus Lamivudine (DTG+3TC) Versus Dolutegravir Plus Tenofovir/Emtricitabine (DTG+TDF/FTC) at 48 Weeks in Antiretroviral Naïve Women: GEMINI Studies Subgroup Analysis

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Early Antenatal Care Visit as it Relates to Prevention of Mother to Child Transmission of HIV in Sub-Saharan Africa

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Adoption of an HIV-Neutral Approach to Pregnancy Care in San Francisco, California

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Adverse Pregnancy Outcomes in HIV-Positive Pregnant Women on ART in Kenya

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Lopinavir (an HIV Protease Inhibitor) Impairs Uterine Remodeling During Pregnancy

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Double-Dose Levonorgestrel Implant Does Not Fully Overcome Drug-Drug Interaction with Efavirenz

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Altered Levels of Bioactive Lipids in HIV and cART-Exposed Pregnancy

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Women’s Involvement in Clinical Research: Women Included in Dolutegravir Clinical Trials Versus Collaborative Studies

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Vaginal Microbiome and Associations with Tenofovir Diphosphate and Lamivudine Triphosphate in Cervical Tissues of Ugandan Women

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Intimate Partner Violence, Depression, and Mortality Among a Cohort of Women Living with HIV Marginalized by Socio-Structural Inequities in Vancouver, Canada

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Dolutegravir Pharmacokinetics During Pregnancy and Postpartum

Abstract

HIV

RSV

International Workshop on HIV & Women 2019

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

Efficacy of Two-Drug Regimen of Dolutegravir Plus Lamivudine (DTG+3TC) Versus Dolutegravir Plus Tenofovir/Emtricitabine (DTG+TDF/FTC) at 48 Weeks in Antiretroviral Naïve Women: GEMINI Studies Subgroup Analysis

Early Antenatal Care Visit as it Relates to Prevention of Mother to Child Transmission of HIV in Sub-Saharan Africa

Adoption of an HIV-Neutral Approach to Pregnancy Care in San Francisco, California

Adverse Pregnancy Outcomes in HIV-Positive Pregnant Women on ART in Kenya

Lopinavir (an HIV Protease Inhibitor) Impairs Uterine Remodeling During Pregnancy

Double-Dose Levonorgestrel Implant Does Not Fully Overcome Drug-Drug Interaction with Efavirenz

Altered Levels of Bioactive Lipids in HIV and cART-Exposed Pregnancy

Women’s Involvement in Clinical Research: Women Included in Dolutegravir Clinical Trials Versus Collaborative Studies

Vaginal Microbiome and Associations with Tenofovir Diphosphate and Lamivudine Triphosphate in Cervical Tissues of Ugandan Women

Intimate Partner Violence, Depression, and Mortality Among a Cohort of Women Living with HIV Marginalized by Socio-Structural Inequities in Vancouver, Canada

Dolutegravir Pharmacokinetics During Pregnancy and Postpartum

Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIV